Last update:

Clinical pharmacology news

Are psychedelics better than antidepressants? New study says no

Psychedelic-assisted therapy may be no more effective than traditional antidepressants when patients know what drugs they are actually taking, according to a first-of-its kind analysis that compared how well each type of ...

FDA-approved compound promotes neuroprotective effects in Parkinson's disease

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), simultaneously targets ...

Scientists find promising drug target for tuberculosis

Researchers from Imperial and the London School of Hygiene & Tropical Medicine (LSHTM) have discovered a drug target that could potentially help tackle drug-resistant tuberculosis, one of the biggest causes of death worldwide.

New video series boosts safe psychotropic use in aged care

Researchers at Monash University and Flinders University have launched a series of microlearning education videos designed to support safer, more appropriate use of psychotropic medications for people living with dementia ...

New coffee chemicals show promise for managing type 2 diabetes

Coffee may do more than boost energy. New research suggests that certain compounds found in roasted coffee beans could help slow how quickly sugar enters the bloodstream, a finding that could one day support new foods aimed ...

Potential new treatment for sepsis

Griffith University researchers may have unlocked the secret to treating sepsis, with a Phase II clinical trial in China successfully concluding with promising results.

Study focuses on safer opioid prescribing

With an estimated 5 million Americans battling opioid use disorder—resulting in tens of thousands of deaths each year—a new study by the University of Texas at Arlington examines how updated Centers for Disease Control ...

The journey of the molecule behind a male birth control pill

A newly published manuscript authored by Dr. Gunda Georg, YourChoice Therapeutics and Columbia University Medical Center describes the chemical journey of YCT-529, a non-hormonal male birth control pill, and the promising ...